Ibex Investors LLC Prestige Consumer Healthcare Inc. Transaction History

Ibex Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$29.93 - $36.8 $706,707 - $868,921	-23,612 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$27.65 - $31.68 $63,677 - $72,959	-2,303 Reduced 8.89%	23,612 $748,000
Q1 2019 May 07, 2019	SELL	$26.79 - $31.72 $28,129 - $33,306	-1,050 Reduced 3.89%	25,915 $775,000
Q4 2018 Feb 13, 2019	SELL	$29.28 - $41.29 $205,340 - $289,566	-7,013 Reduced 20.64%	26,965 $833,000
Q3 2018 Nov 13, 2018	BUY	$34.44 - $39.35 $1.17 Million - $1.34 Million	33,978 New	33,978 $1.29 Million

337

50.4M

6.3K

Ticker PBH
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,762,600
Market Cap $4.1B
Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.